Skip to main content

Advertisement

Log in

Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

This article aims to evaluate the possible effect of obesity on quality of life, psychological status, and other clinical variables in Psoriatic arthritis (PsA). PsA patients have been recruited by the Turkish League Against Rheumatism-Network from various centers in Turkey in this cross-sectional study. Patients with a body mass index (BMI) ≥ of 30 kg/m2 were considered obese. Differences among patients with regard to obesity status were assessed with health-related quality of life measures (PsA Quality of Life Questionnaire [PsAQoL]), psychological status (Hospital Anxiety and Depression Scale [HADS]), and disease activity parameters (the Disease Activity index for PSoriatic Arthritis [DAPSA], Disease Activity Score 28-C-reactive protein [DAS28-CRP], Bath Ankylosing Spondylitis Disease Activity Index [BASDAI], Psoriasis Area and Severity Index [PASI]), physical functions (Ankylosing Spondylitis Functional Index [BASFI], Health Assessment Questionnaire [HAQ], and Health Assessment Questionnaire for the spondyloarthropathies [HAQ-S]). Pain was assessed using visual analog scale of pain (VAS-P), and fatigue was evaluated using visual analog scale of fatigue (VAS-F) and Functional Assessment of Chronic Illness Therapy (FACIT). A total of 1033 patients with PsA, 650 (62.9%) non-obese and 383 (37.1%) obese were included in the study. The PsAQoL, HADS-Anxiety, HADS-Depression, DAPSA, DAS28-CRP, BASDAI, BASFI, HAQ and HAQ-S scores of the obese group were higher than the non-obese group (p < 0.05). VAS-P and PASI scores were similar between group of patients with and without obesity. Obese patients had higher median scores of VAS-F and FACIT than non-obese patients (p < 0.05). Linear regression analysis showed that BMI affects the quality of life, depression, and disease activity. Consequently, obesity has significant associations with higher disease activity, lower QoL, risk of anxiety, depression, and fatigue. Therefore, obesity should also be taken into account in the management of PsA patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376(10):957–970. https://doi.org/10.1056/NEJMra1505557

    Article  PubMed  Google Scholar 

  2. Queiro R, Lorenzo A, Tejon P, Coto P, Pardo E (2019) Obesity in psoriatic arthritis: comparative prevalence and associated factors. Medicine (Baltimore) 98(28):e16400. https://doi.org/10.1097/MD.0000000000016400

    Article  Google Scholar 

  3. Solomon DH, Love TJ, Canning C, Schneeweiss S (2010) Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 69(12):2114–2117. https://doi.org/10.1136/ard.2009.125476

    Article  PubMed  Google Scholar 

  4. Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, Gladman DD (2011) Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res 63(12):1729–1735. https://doi.org/10.1002/acr.20627

    Article  Google Scholar 

  5. Perez-Chada LM, Merola JF (2020) Comorbidities associated with psoriatic arthritis: review and update. Clin Immunol (Orlando, Fla) 214:108397. https://doi.org/10.1016/j.clim.2020.108397

    Article  CAS  Google Scholar 

  6. Gupta S, Syrimi Z, Hughes DM, Zhao SS (2021) Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int 41(2):275–284. https://doi.org/10.1007/s00296-020-04775-2

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bhole VM, Choi HK, Burns LC, Vera Kellet C, Lacaille DV, Gladman DD, Dutz JP (2012) Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford) 51(3):552–556. https://doi.org/10.1093/rheumatology/ker349

    Article  Google Scholar 

  8. Divella R, De Luca R, Abbate I, Naglieri E, Daniele A (2016) Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer 7(15):2346–2359. https://doi.org/10.7150/jca.16884

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Van Raemdonck K, Umar S, Szekanecz Z, Zomorrodi RK, Shahrara S (2018) Impact of obesity on autoimmune arthritis and its cardiovascular complications. Autoimmun Rev 17(8):821–835. https://doi.org/10.1016/j.autrev.2018.02.007

    Article  PubMed  Google Scholar 

  10. Porta S, Otero-Losada M, Kölliker Frers RA, Cosentino V, Kerzberg E, Capani F (2020) Adipokines, cardiovascular risk, and therapeutic management in obesity and psoriatic arthritis. Front Immunol 11:590749. https://doi.org/10.3389/fimmu.2020.590749

    Article  CAS  PubMed  Google Scholar 

  11. Love TJ, Zhu Y, Zhang Y, Wall-Burns L, Ogdie A, Gelfand JM, Choi HK (2012) Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis 71(8):1273–1277. https://doi.org/10.1136/annrheumdis-2012-201299

    Article  PubMed  Google Scholar 

  12. Li W, Han J, Qureshi AA (2012) Obesity and risk of incident psoriatic arthritis in US women. Ann Rheum Dis 71(8):1267–1272. https://doi.org/10.1136/annrheumdis-2011-201273

    Article  PubMed  Google Scholar 

  13. Azevedo S, Santos-Faria D, Leite Silva J, Ramos Rodrigues J, Sousa Neves J, Peixoto D, Tavares-Costa J, Alcino S, Afonso C, Teixeira F (2019) Obesity, metabolic syndrome and other comorbidities in rheumatoid arthritis and psoriatic arthritis: influence on disease activity and quality of life. Acta Reumatol Portuguesa 44(4):322–324

    Google Scholar 

  14. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673. https://doi.org/10.1002/art.21972

    Article  PubMed  Google Scholar 

  15. McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ (2004) Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 63(2):162–169. https://doi.org/10.1136/ard.2003.006296

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x

    Article  CAS  PubMed  Google Scholar 

  17. Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS (2010) Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 69(8):1441–1447. https://doi.org/10.1136/ard.2009.122259

    Article  PubMed  Google Scholar 

  18. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21(12):2286–2291

    CAS  PubMed  Google Scholar 

  19. Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285

    CAS  PubMed  Google Scholar 

  20. Fries JF, Spitz PW, Young DY (1982) The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 9(5):789–793

    CAS  PubMed  Google Scholar 

  21. Daltroy LH, Larson MG, Roberts NW, Liang MH (1990) A modification of the health assessment questionnaire for the spondyloarthropathies. J Rheumatol 17(7):946–950

    CAS  PubMed  Google Scholar 

  22. Feldman SR, Fleischer AB Jr, Reboussin DM, Rapp SR, Exum ML, Clark AR, Nurre L (1996) The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 106(1):183–186. https://doi.org/10.1111/1523-1747.ep12329912

    Article  CAS  PubMed  Google Scholar 

  23. Webster K, Cella D, Yost K (2003) The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1:79. https://doi.org/10.1186/1477-7525-1-79

    Article  PubMed  PubMed Central  Google Scholar 

  24. Coto-Segura P, Eiris-Salvado N, González-Lara L, Queiro-Silva R, Martinez-Camblor P, Maldonado-Seral C, García-García B, Palacios-García L, Gomez-Bernal S, Santos-Juanes J, Coto E (2013) Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis. Br J Dermatol 169(4):783–793. https://doi.org/10.1111/bjd.12473

    Article  CAS  PubMed  Google Scholar 

  25. Dubreuil M, Rho YH, Man A, Zhu Y, Zhang Y, Love TJ, Ogdie A, Gelfand JM, Choi HK (2014) Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. Rheumatology (Oxford) 53(2):346–352. https://doi.org/10.1093/rheumatology/ket343

    Article  CAS  Google Scholar 

  26. Haroon M, Gallagher P, Heffernan E, FitzGerald O (2014) High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease. J Rheumatol 41(7):1357–1365. https://doi.org/10.3899/jrheum.140021

    Article  PubMed  Google Scholar 

  27. Ogdie A, Schwartzman S, Husni ME (2015) Recognizing and managing comorbidities in psoriatic arthritis. Curr Opin Rheumatol 27(2):118–126. https://doi.org/10.1097/bor.0000000000000152

    Article  PubMed  Google Scholar 

  28. Loganathan A, Kamalaraj N, El-Haddad C, Pile K (2021) Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis. Int J Rheum Dis. https://doi.org/10.1111/1756-185x.14147

    Article  PubMed  Google Scholar 

  29. Labitigan M, Bahče-Altuntas A, Kremer JM, Reed G, Greenberg JD, Jordan N, Putterman C, Broder A (2014) Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res 66(4):600–607. https://doi.org/10.1002/acr.22185

    Article  CAS  Google Scholar 

  30. Thomsen RS, Nilsen TIL, Haugeberg G, Gulati AM, Kavanaugh A, Hoff M (2021) Adiposity and physical activity as risk factors for developing psoriatic arthritis: longitudinal data from a population-based study in Norway. Arthritis Care Res 73(3):432–441. https://doi.org/10.1002/acr.24121

    Article  Google Scholar 

  31. Soltani-Arabshahi R, Wong B, Feng BJ, Goldgar DE, Duffin KC, Krueger GG (2010) Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol 146(7):721–726. https://doi.org/10.1001/archdermatol.2010.141

    Article  PubMed  Google Scholar 

  32. Nas K, Kiliç E, Tekeoğlu İ, Keskin Y, Çevik R, Sargin B, Acer Kasman S, Alkan H, Sahin N, Cengiz G, Cüzdan N, Albayrak Gezer İ, Keskin D, Mülkoglu C, Reşorlu H, Ataman Ş, Bal A, Baykul M, Duruöz MT, Küçükakkaş O, Yurdakul OV, Alkan Melikoğlu M, Ayhan FF, Bodur H, Çaliş M, Çapkin E, Devrimsel G, Gök K, Hizmetli S, Kamanlı A, Kocabaş H, Kutluk Ö, Şen N, Şendur ÖF, Toprak M, Tolu S, Tuncer T (2021) The effect of gender on disease activity and clinical characteristics in patients with axial psoriatic arthritis. Mod Rheumatol 31(4):869–874. https://doi.org/10.1080/14397595.2020.1812870

    Article  PubMed  Google Scholar 

  33. Kalyoncu U, Bayindir Ö, Ferhat Öksüz M, Doğru A, Kimyon G, Tarhan EF, Erden A, Yavuz Ş, Can M, Çetin GY, Kılıç L, Küçükşahin O, Omma A, Ozisler C, Solmaz D, Bozkirli ED, Akyol L, Pehlevan SM, Gunal EK, Arslan F, Yılmazer B, Atakan N, Aydın SZ (2017) The psoriatic arthritis registry of Turkey: results of a multicentre registry on 1081 patients. Rheumatology (Oxford) 56(2):279–286. https://doi.org/10.1093/rheumatology/kew375

    Article  Google Scholar 

  34. Eder L, Thavaneswaran A, Chandran V, Cook RJ, Gladman DD (2015) Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Ann Rheum Dis 74(5):813–817. https://doi.org/10.1136/annrheumdis-2013-204448

    Article  PubMed  Google Scholar 

  35. Moroni L, Farina N, Dagna L (2020) Obesity and its role in the management of rheumatoid and psoriatic arthritis. Clin Rheumatol 39(4):1039–1047. https://doi.org/10.1007/s10067-020-04963-2

    Article  PubMed  Google Scholar 

  36. Kumthekar A, Ogdie A (2020) Obesity and psoriatic arthritis: a narrative review. Rheumatol Ther 7(3):447–456. https://doi.org/10.1007/s40744-020-00215-6

    Article  PubMed  PubMed Central  Google Scholar 

  37. Klingberg E, Bilberg A, Björkman S, Hedberg M, Jacobsson L, Forsblad-d’Elia H, Carlsten H, Eliasson B, Larsson I (2019) Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study. Arthritis Res Ther 21(1):17. https://doi.org/10.1186/s13075-019-1810-5

    Article  PubMed  PubMed Central  Google Scholar 

  38. Ballegaard C, Skougaard M, Guldberg-Møller J, Nissen CV, Amris K, Jørgensen TS, Dreyer L, Kristensen LE (2021) Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: a clinical cohort study. Rheumatology (Oxford) 60(7):3289–3300. https://doi.org/10.1093/rheumatology/keaa780

    Article  Google Scholar 

  39. Michelsen B, Uhlig T, Sexton J, van der Heijde D, Hammer HB, Kristianslund EK, Wierød A, Bakland G, Rødevand E, Krøll F, Loge JH, Haugeberg G, Kvien TK (2018) Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls. Ann Rheum Dis 77(9):1290–1294. https://doi.org/10.1136/annrheumdis-2018-213286

    Article  PubMed  Google Scholar 

  40. Wervers K, Luime JJ, Tchetverikov I, Gerards AH, Kok MR, Appels CWY, van der Graaff WL, van Groenendael J, Korswagen LA, Veris-van Dieren JJ, Hazes JMW, Vis M (2018) Influence of disease manifestations on health-related quality of life in early psoriatic arthritis. J Rheumatol 45(11):1526–1531. https://doi.org/10.3899/jrheum.171406

    Article  PubMed  Google Scholar 

  41. Azad N, Gondal M, Abbas N (2008) Frequency of depression and anxiety in patients attending a rheumatology clinic. J College Phys Surg Pak: JCPSP 18(9):569–573

    Google Scholar 

  42. Geenen R, Newman S, Bossema ER, Vriezekolk JE, Boelen PA (2012) Psychological interventions for patients with rheumatic diseases and anxiety or depression. Best Pract Res Clin Rheumatol 26(3):305–319. https://doi.org/10.1016/j.berh.2012.05.004

    Article  PubMed  Google Scholar 

  43. Husni ME, Merola JF, Davin S (2017) The psychosocial burden of psoriatic arthritis. Semin Arthritis Rheum 47(3):351–360. https://doi.org/10.1016/j.semarthrit.2017.05.010

    Article  PubMed  Google Scholar 

  44. Peterson S, Piercy J, Blackburn S, Sullivan E, Karyekar CS, Li N (2019) The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis. BMC Rheumatol 3:43. https://doi.org/10.1186/s41927-019-0092-5

    Article  PubMed  PubMed Central  Google Scholar 

  45. Bavière W, Deprez X, Houvenagel E, Philippe P, Deken V, Flipo RM, Paccou J (2020) Association between comorbidities and quality of life in psoriatic arthritis: results from a multicentric cross-sectional study. J Rheumatol 47(3):369–376. https://doi.org/10.3899/jrheum.181471

    Article  PubMed  Google Scholar 

  46. Duruöz MT, Gezer HH, Nas K, Kilic E, Sargin B, Acer Kasman S, Alkan H, Sahin N, Cengiz G, Cuzdan N, Albayrak Gezer İ, Keskin D, Mulkoglu C, Resorlu H, Ataman S, Bal A, Kucukakkas O, Yurdakul OV, Melikoglu MA, Ayhan FF, Baykul M, Bodur H, Calis M, Capkin E, Devrimsel G, Gök K, Hizmetli S, Kamanlı A, Keskin Y, Ecesoy H, Kutluk Ö, Sen N, Sendur ÖF, Tekeoglu İ, Tolu S, Toprak M, Tuncer T (2020) The impact of fatigue on patients with psoriatic arthritis: a multi-center study of the TLAR-network. Rheumatol Int 40(11):1803–1815. https://doi.org/10.1007/s00296-020-04628-y

    Article  PubMed  Google Scholar 

  47. Kotsis K, Voulgari PV, Tsifetaki N, Machado MO, Carvalho AF, Creed F, Drosos AA, Hyphantis T (2012) Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life. Arthritis Care Res 64(10):1593–1601. https://doi.org/10.1002/acr.21725

    Article  Google Scholar 

  48. McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, Gladman DD (2014) Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol 41(5):887–896. https://doi.org/10.3899/jrheum.130797

    Article  PubMed  Google Scholar 

  49. Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN (2008) Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 67(5):672–676. https://doi.org/10.1136/ard.2007.073932

    Article  CAS  PubMed  Google Scholar 

  50. Højgaard P, Glintborg B, Kristensen LE, Gudbjornsson B, Love TJ, Dreyer L (2016) The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries. Rheumatology (Oxford) 55(12):2191–2199. https://doi.org/10.1093/rheumatology/kew326

    Article  CAS  Google Scholar 

  51. Eder L, Abji F, Rosen CF, Chandran V, Gladman DD (2017) The association between obesity and clinical features of psoriatic arthritis: a case-control study. J Rheumatol 44(4):437–443. https://doi.org/10.3899/jrheum.160532

    Article  PubMed  Google Scholar 

  52. di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Scarpa R, di Minno G (2013) Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis. Arthritis Care Res 65(1):141–147. https://doi.org/10.1002/acr.21711

    Article  Google Scholar 

  53. Scher JU, Ogdie A, Merola JF, Ritchlin C (2019) Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol 15(3):153–166. https://doi.org/10.1038/s41584-019-0175-0

    Article  PubMed  Google Scholar 

  54. George MD, Giles JT, Katz PP, England BR, Mikuls TR, Michaud K, Ogdie-Beatty AR, Ibrahim S, Cannon GW, Caplan L, Sauer BC, Baker JF (2017) Impact of obesity and adiposity on inflammatory markers in patients with rheumatoid arthritis. Arthritis Care Res 69(12):1789–1798. https://doi.org/10.1002/acr.23229

    Article  Google Scholar 

Download references

Funding

The authors received no financial support for the research.

Author information

Authors and Affiliations

Authors

Contributions

All authors have contributions to the study conception, design and data collection. Literature search was performed by KG. Analysis and interpretation of data were performed by KG, KN, IT, IS, and YK. The first draft of the manuscript was written by KG. KG, KN, IT, and YK participated in drafting and revise the work. All authors commented on previous versions of the manuscript and have approved the final version of the manuscript. KN had full access to all of the data in the study and takes responsibility for the integrity of the data. All co-authors are fully accountable for all aspects of the work and the final manuscript in line with the IJME 4 criteria.

Corresponding author

Correspondence to Kevser Gok.

Ethics declarations

Conflict of interest

Authors declare no conflict of interest.

Ethical approval

Ethical approval was taken from the Sakarya University Ethics Committee on 25.01.2018. The protocol number was 42 and conducted in accordance with the Helsinki Declaration.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gok, K., Nas, K., Tekeoglu, I. et al. Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study. Rheumatol Int 42, 659–668 (2022). https://doi.org/10.1007/s00296-021-04971-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-021-04971-8

Keywords

Navigation